Taiwan Study Reports Higher Lung-Cancer Risks In TB Patients
This article was originally published in PharmAsia News
A Taiwanese study suggests tuberculosis patients are 11 times more at risk for lung cancer than those who have not had TB. Researchers reported their results based on 700,00 participants in a six-year study, 4,480 of them diagnosed with TB. The China Medical University research team suggested the findings show it is important to stress cancer prevention as a theme in anti-TB campaigns. (Click here for more
You may also be interested in...
Third quarter earnings show Gilead’s Immunomedics buy paid off, but filgotinib’s path may narrow. The HIV and HCV franchises picked up from their COVID-19 lull.
US pharmacy group says that 10 to 12 states have indicated through an informal survey that they do not have the manpower or funding to implement the US FDA’s final MOU on inordinate compounding. They say what is at stake in these states is patient access to compounded medicines.
Mayo Clinic announces AI-based partnerships with Google and voice-analysis company Vocalis Health this week.